| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$104 |
Lumos secures follow-on PKU contract with Aptatek
|
1 Sep 2025 9:28AM |
$0.125 |
$0.110 |
fallen by
12%
|
|
LDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Lumos secures follow-on contract with Aptatek for PKU in-home monitoring device.
- Contract valued at approximately USD 1.5 million, commencing September 2025.
- Device allows real-time monitoring of phenylalanine levels for PKU patients.
- Initial collaboration phase generated USD 0.5 million in revenue for Lumos.
- Device has FDA Breakthrough Device designation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$104 |
Lumos secures follow-on PKU contract with Aptatek
|
1 Sep 2025 9:28AM |
$0.125 |
$0.110 |
fallen by
12%
|
|
LDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Lumos Diagnostics secures a follow-on contract with Aptatek Biosciences.
- The project involves developing an in-home monitoring device for Phenylketonuria (PKU).
- The contract is valued at approximately US$1.5 million.
- The collaboration started in June 2022 with an initial phase generating US$0.5 million.
- The device is designed to help PKU patients monitor phenylalanine levels from home.
- The device has received FDA Breakthrough Device designation.
- The follow-on contract will focus on design maturation and formal verification.
- Anticipated to commence in September 2025 and run for about 10 months.
- The project aims to transform PKU management with reliable at-home monitoring.
- Lumos Diagnostics is a leader in rapid diagnostic technologies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$277 |
Weekly Estimated NTA as at 29 August 2025
|
1 Sep 2025 9:28AM |
$1.065 |
$0.880 |
fallen by
17.37%
|
|
| wrkr Ltd (WRK) ORDINARY FULLY PAID |
Information Technology |
$175 |
Vesting of Staff Incentives
|
1 Sep 2025 9:27AM |
$0.110 |
$0.088 |
fallen by
20%
|
|
| Australian Foundation Investment Company Limited (AFI) ORDINARY FULLY PAID |
Financials |
$8,514 |
Weekly Estimated NTA as at 29 August 2025
|
1 Sep 2025 9:27AM |
$7.330 |
$6.890 |
fallen by
6%
|
|
| Amaero Ltd (3DA) CHESS DEPOSITARY INTERESTS 40:1 |
Industrials |
$243 |
Titomic Selects Amaero as Sole Supplier of Powders
|
1 Sep 2025 9:26AM |
$0.385 |
$0.255 |
fallen by
33.77%
|
|
3DA - Price-sensitive ASX Announcement
Full Release
Key Points
- Amaero and Titomic enter a five-year exclusive supply agreement.
- Amaero to supply spherical refractory and titanium alloy powders.
- Focus on defense, space, and aerospace applications.
- Collaboration leverages Amaero's production with Titomic's manufacturing expertise.
- Aims to enhance domestic supply chain resilience.
- Expected to contribute 5%-10% of Amaero’s FY2026 revenue.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lightning Minerals Ltd (L1M) ORDINARY FULLY PAID |
Materials |
$5 |
Application for quotation of securities - L1M
|
1 Sep 2025 9:26AM |
$0.038 |
$0.015 |
fallen by
60.53%
|
|
| Titomic Limited (TTT) ORDINARY FULLY PAID |
Materials |
$338 |
Amaero and Titomic Establish Strategic Supply Agreement
|
1 Sep 2025 9:26AM |
$0.260 |
$0.210 |
fallen by
19.23%
|
|
TTT - Price-sensitive ASX Announcement
Full Release
Key Points
- Titomic Limited and Amaero Ltd have signed a five-year Strategic Supply and Development Agreement.
- Amaero will be the exclusive supplier of spherical refractory and titanium alloy powders.
- The agreement supports Titomic's cold spray technology for defense, space, and aerospace applications.
- The partnership ensures a resilient and scalable U.S. domestic supply chain.
- Pricing will be reviewed semi-annually and is linked to the landed cost of the feedstock.
- Exclusivity allows Titomic to source elsewhere if Amaero cannot meet certification or delivery timeframes.
- The agreement involves mutual development and testing, sharing data and intellectual property.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clever Culture Systems Limited (CC5) ORDINARY FULLY PAID |
Health Care |
$48 |
Notification of cessation of securities - CC5
|
1 Sep 2025 9:26AM |
$0.032 |
$0.022 |
fallen by
31.25%
|
|
| Clime Investment Management Ltd (CIW) ORDINARY FULLY PAID |
Financials |
$24 |
FY25 Results and Dividend Declaration
|
1 Sep 2025 9:26AM |
$0.390 |
$0.295 |
fallen by
24.36%
|
|
CIW - Price-sensitive ASX Announcement
Full Release
Key Points
- FY25 pretax and amortisation profit of $2.1 million.
- Significant $5 million improvement over FY24.
- Final dividend of 0.5 cents per share declared.
- Noncash amortisation and impairment charges accounted.
- Strategic initiatives planned for FY26.
- Focus on expanding market offerings and client engagement.
- Investment in technology and digital communications.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clime Investment Management Ltd (CIW) ORDINARY FULLY PAID |
Financials |
$24 |
FY25 Results and Dividend Declaration
|
1 Sep 2025 9:26AM |
$0.390 |
$0.295 |
fallen by
24.36%
|
|
CIW - Price-sensitive ASX Announcement
Full Release
Key Points
- CIW posts strong FY25 profit with a pretax and amortisation profit of $2.1 million.
- Declared a final dividend of 0.5 cents per share, fully franked, payable on 24 October.
- Reported a $5 million improvement over FY24 results.
- Incurred $271k abnormal net charge due to restructuring and redundancy costs.
- Revaluation gain from Infocus Wealth convertible notes offset IT and legal expenses.
- Noncash amortisation and impairment charges affected reported profits.
- Strategic focus on expanding product and advice offerings in FY26.
- Plans to enhance market presence through direct and digital communications.
- Target to increase operating margins to 20% in FY26 and 30% in the medium term.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Equigold NL (EQI) ORDINARY FULLY PAID |
Materials |
- |
Admission and Commencement of Trading - EQIN
|
1 Sep 2025 9:25AM |
$4.020 |
$4.020 |
fallen by
0%
|
|
| APA Group (APA) FULLY PAID UNITS STAPLED SECURITIES |
Utilities |
$13,516 |
Resignation of Company Secretary
|
1 Sep 2025 9:25AM |
$8.810 |
$10.210 |
risen by
15.89%
|
|
| Dateline Resources Limited (DTR) ORDINARY FULLY PAID |
Materials |
$517 |
Proposed issue of securities - DTR
|
1 Sep 2025 9:24AM |
$0.265 |
$0.135 |
fallen by
49.06%
|
|
| Imagion Biosystems Limited (IBX) ORDINARY FULLY PAID |
Health Care |
$5 |
Dr Nina Webster Appointed to IBX Board of Directors
|
1 Sep 2025 9:24AM |
$0.015 |
$0.011 |
fallen by
26.67%
|
|
| Dateline Resources Limited (DTR) ORDINARY FULLY PAID |
Materials |
$517 |
$25M Institutional Cap Raise Boosts Dateline Funds to $35M
|
1 Sep 2025 9:24AM |
$0.265 |
$0.135 |
fallen by
49.06%
|
|
DTR - Price-sensitive ASX Announcement
Full Release
Key Points
- $25 million institutional placement completed at $0.215 per share.
- Total cash reserves increased to over $35 million.
- Funds to accelerate exploration at Colosseum Gold and REE Project, California.
- Strong U.S. federal support for the project as a critical mineral source.
- Initiation of U.S. SEC registration to comply with reporting standards.
- Support from institutional investors validates the Colosseum Project strategy.
- Focus on drilling campaigns for gold and rare earth targets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dateline Resources Limited (DTR) ORDINARY FULLY PAID |
Materials |
$517 |
$25M Institutional Cap Raise Boosts Dateline Funds to $35M
|
1 Sep 2025 9:24AM |
$0.265 |
$0.135 |
fallen by
49.06%
|
|
DTR - Price-sensitive ASX Announcement
Full Release
Key Points
- $25 million institutional placement completed at $0.215 per share
- Total cash reserves increased to over $35 million
- Funds to accelerate exploration at Colosseum Gold and REE Project
- Strong U.S. government support for Colosseum's mineral potential
- Initiation of U.S. SEC registration to enhance investor appeal
- Identification of new gold targets and REE potential at Colosseum
- Plans for drilling campaigns to expand resources
- Colosseum Project hosts a JORC-compliant resource of 1.1 Moz of gold
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Helloworld Travel Limited (HLO) ORDINARY FULLY PAID |
Consumer Discretionary |
$235 |
HLO 2025 Annual General Meeting
|
1 Sep 2025 9:23AM |
$1.900 |
$1.435 |
fallen by
24.47%
|
|
| Investor Centre Limited (ICU) ORDINARY FULLY PAID |
Financials |
$0 |
Suspension from Quotation
|
1 Sep 2025 9:22AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
| BWE Drilling Ltd (BWE) ORDINARY FULLY PAID |
Industrials |
- |
Suspension from Quotation
|
1 Sep 2025 9:22AM |
$0.280 |
$0.280 |
fallen by
0%
|
|
| Multistack International Limited (MSI) ORDINARY FULLY PAID |
Industrials |
$0 |
Suspension from Quotation
|
1 Sep 2025 9:22AM |
$0.005 |
$0.003 |
fallen by
40%
|
|
MSI - Price-sensitive ASX Announcement
Full Release
Key Points
- Suspension of Multistack International Limited securities by ASX
- Failure to lodge periodic reports by due date
- Suspension effective from 1 September 2025
- Possible reinstatement if reports lodged by specific deadlines
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PRO-PAC Packaging Limited (PPG) ORDINARY FULLY PAID |
Materials |
$3 |
Suspension from Quotation
|
1 Sep 2025 9:22AM |
$0.018 |
$0.018 |
fallen by
0%
|
|
| CAQ Holdings Limited (CAQ) ORDINARY FULLY PAID |
Real Estate |
$6 |
Suspension from Quotation
|
1 Sep 2025 9:22AM |
$0.009 |
$0.009 |
fallen by
0%
|
|
| Gryphon Capital Income Trust (GCI) ORDINARY UNITS FULLY PAID |
Financials |
$1,316 |
Update - Dividend/Distribution - GCI
|
1 Sep 2025 9:21AM |
$2.050 |
$2.070 |
risen by
0.98%
|
|
| Little Green Pharma Ltd (LGP) ORDINARY FULLY PAID |
Health Care |
$52 |
Application for quotation of securities - LGP
|
1 Sep 2025 9:21AM |
$0.123 |
$0.063 |
fallen by
48.57%
|
|
Call 1300 880 160
Start a chat
Schedule a call
